Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BioSante reports phase III LibiGel safety data

Feb. 23, 2010

PPARdelta agonists discovered at sanofi-aventis

Feb. 23, 2010

EnzymeRx provides clinical update on pegsitacase

Feb. 23, 2010

FDA sets PDUFA action date for Amgen's complete response submission for Prolia

Feb. 22, 2010

Pivotal Research adds U.S. center to phase II study of VA-111913 for dysmenorrhea

Feb. 18, 2010

BioMimetic completes submission of PMA to FDA for Augment Bone Graft

Feb. 18, 2010

Genfit reports the identification of novel PPAR agonists

Feb. 18, 2010

Marcadia Biotech initiates phase I trial of MAR-701

Feb. 18, 2010

Repros submits response to FDA regarding Androxal in hypogonadism

Feb. 16, 2010

3SBio submits application in China for phase I clinical trial of NuPIAO

Feb. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...